Doximity, Inc. (NYSE:DOCS) Receives $55.00 Average Price Target from Brokerages

Shares of Doximity, Inc. (NYSE:DOCSGet Free Report) have been assigned an average recommendation of “Buy” from the nine brokerages that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and three have issued a strong buy recommendation on the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $44.50.

Several equities analysts have recently issued reports on DOCS shares. Barclays upgraded shares of Doximity to a “strong-buy” rating in a report on Monday, December 8th. The Goldman Sachs Group upgraded Doximity from a “strong sell” rating to a “hold” rating in a research note on Friday, January 9th. Needham & Company LLC raised Doximity to a “moderate buy” rating in a report on Friday, February 6th. Canaccord Genuity Group upgraded Doximity from a “hold” rating to a “buy” rating and set a $34.00 price objective on the stock in a report on Monday. Finally, Royal Bank Of Canada upgraded Doximity to a “moderate buy” rating in a research note on Thursday, January 8th.

Read Our Latest Stock Report on DOCS

Doximity Stock Performance

Doximity stock opened at $27.28 on Wednesday. The stock has a market cap of $5.14 billion, a PE ratio of 22.73, a price-to-earnings-growth ratio of 1.51 and a beta of 1.39. The company has a 50 day moving average price of $40.81. Doximity has a 1-year low of $23.66 and a 1-year high of $80.25.

About Doximity

(Get Free Report)

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.

Read More

Analyst Recommendations for Doximity (NYSE:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.